ZOSYN Safety Questions, ZOSYN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ZOSYN. Our extensive database of ZOSYN adverse events and ZOSYN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ZOSYN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ZOSYN Safety Reports

Total ZOSYN reports: 71.
ZOSYN FDA safety alerts: No.
Reported deaths: 7    Reported hospitalizations: 31.
Take ZOSYN Side Effects Survey or Share Your ZOSYN Story. ZOSYN Usage.

Pharmacist from UNITED STATES reported ZOSYN problem on Jan 05, 2007. Male patient, 80 years of age, weighting 201.9 lb, was diagnosed with osteomyelitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: red blood cell count decreased, thrombocytopenia. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Jan 31, 2007. Male patient, 65 years of age, weighting 220.0 lb, was diagnosed with sepsis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, infusion related reaction, oxygen saturation decreased. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Feb 01, 2007. Female patient, weighting 150.0 lb, was diagnosed with chronic sinusitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: white blood cell count decreased. ZOSYN dosage: unknown. During the same period patient was treated with TRAZODONE, WELLBUTRIN, ZETIA, UNIPHYL, SINGULAIR, TOPROL, BACLOFEN. Patient recovered.

ZOSYN problem was reported by a Health Professional from UNITED STATES on Jan 25, 2007. Female patient, 53 years of age, was diagnosed with abdominal infection and was treated with ZOSYN. ZOSYN dosage: unknown. Patient died on 11/01/2006.

Pharmacist from UNITED STATES reported ZOSYN problem on Feb 06, 2007. Female patient, 91 years of age, weighting 160.1 lb, was diagnosed with localised infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. ZOSYN dosage: unknown. During the same period patient was treated with ATACAND, TIMOLOL MALEATE. Patient recovered.

ZOSYN problem was reported by a Health Professional from UNITED STATES on Feb 09, 2007. Male patient, 21 years of age, weighting 111.0 lb, was diagnosed with beta haemolytic streptococcal infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Feb 14, 2007. Male patient, 79 years of age, was diagnosed with nosocomial infection, sepsis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: sepsis, thrombocytopenia. ZOSYN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ALBUTEROL, ASPIRIN, CARVEDILOL, CITALOPRAM HYDROBROMIDE, FUROSEMIDE, HEPARIN. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Feb 14, 2007. Male patient, 54 years of age, weighting 185.0 lb, was diagnosed with cellulitis, osteomyelitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, eosinophil count increased, fatigue, hypotension, malaise, pyrexia, rash, white blood cell count decreased, white blood cell count increased. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOSYN problem on Feb 20, 2007. Male patient, 58 years of age, weighting 147.5 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: rash. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Physician from UNITED STATES on Aug 22, 2006. Female patient was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased, platelet count decreased. ZOSYN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ZOSYN problem on Dec 02, 2005. Female patient, 78 years of age, weighting 176.4 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. ZOSYN dosage: unknown. During the same period patient was treated with LOPRESSOR, CARDIZEM. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Jan 16, 2006. Female patient, 55 years of age, weighting 329.3 lb, was diagnosed with arthritis bacterial and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. ZOSYN dosage: unknown. During the same period patient was treated with LEXAPRO, INSULIN, PLAVIX, NEURONTIN, METOPROLOL TARTRATE, SENOKOT, ALBUTEROL, PROTONIX. Patient recovered.

Health Professional from UNITED STATES reported ZOSYN problem on Nov 04, 2005. Female patient, 87 years of age, was diagnosed with bacteraemia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. ZOSYN dosage: unknown. During the same period patient was treated with VANCOMYCIN. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2006. Male patient, 90 years of age, was diagnosed with pneumonia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, rash pruritic, urinary tract infection. ZOSYN dosage: unknown. During the same period patient was treated with ARICEPT. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Mar 02, 2007. Male patient, weighting 161.0 lb, was diagnosed with cystic fibrosis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, headache, nausea, palpitations, vomiting. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient, weighting 161.0 lb, was diagnosed with cystic fibrosis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, headache, nausea, palpitations, vomiting. ZOSYN dosage: unknown. During the same period patient was treated with TOBRAMYCIN, ALBUTEROL, ZITHROMAX, CREON, PULMOZYME, FLOVENT, ADEKS. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Mar 02, 2007. Male patient, 71 years of age, weighting 222.7 lb, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, international normalised ratio increased, leukopenia, prothrombin time prolonged, thrombocytopenia. ZOSYN dosage: unknown. During the same period patient was treated with LINEZOLID, APAP, DUONEB, VIT C, FERROUS SULPHATE, FLUCONAZOLE, HEPARIN LOCK, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2007. Female patient, 43 years of age, weighting 195.1 lb, was diagnosed with pneumonia, pulmonary cavitation and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: granulocytosis, leukopenia. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Apr 03, 2007. Male patient, weighting 280.0 lb, was diagnosed with infection, hyperuricaemia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. ZOSYN dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Apr 04, 2007. Male patient, weighting 106.5 lb, was diagnosed with appendiceal abscess, pseudomonas infection, streptococcal infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: white blood cell count decreased. ZOSYN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Apr 09, 2007. Male patient, 43 years of age, weighting 235.9 lb, was diagnosed with abdominal infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: oedema, rash. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Apr 11, 2007. Male patient, 79 years of age, weighting 186.1 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: rash. ZOSYN dosage: unknown. Patient died on 03/17/2007.

Health Professional from UNITED STATES reported ZOSYN problem on Apr 17, 2007. Female patient, 40 years of age, weighting 229.0 lb, was diagnosed with enterococcal infection, fungus body fluid identified, fungus sputum test positive, bacteria sputum identified and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. ZOSYN dosage: unknown. During the same period patient was treated with CANCIDAS. Patient recovered.

ZOSYN problem was reported by a Physician from UNITED STATES on Apr 23, 2007. Male patient, 66 years of age, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZOSYN problem on Apr 18, 2007. Male patient, weighting 153.1 lb, was diagnosed with peritonitis, escherichia infection, bacteroides infection, clostridial infection, metastatic renal cell carcinoma and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, post procedural complication. ZOSYN dosage: unknown. During the same period patient was treated with SUNITINIB, TEMSIROLIMUS, COLACE, PROTONIX, OXYCONTIN. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on May 03, 2007. Male patient, 88 years of age, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: pancytopenia. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZOSYN problem on May 23, 2007. Male patient, child 9 years of age, weighting 74.00 lb, was diagnosed with appendicitis perforated and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: laboratory test abnormal, neutropenia, white blood cell count decreased. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on May 23, 2007. Female patient, 51 years of age, weighting 116.0 lb, was diagnosed with lung infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count decreased. ZOSYN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on June 14, 2007. Female patient, 79 years of age, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: rash, urticaria. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Health Professional from UNITED STATES on June 15, 2007. Female patient, 52 years of age, weighting 125.7 lb, was diagnosed with cellulitis, skin infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: rash maculo-papular. ZOSYN dosage: 4.5GM INJ 100ML D5W IVPB Q 8 H IV. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on June 25, 2007. Male patient, weighting 198.4 lb, was diagnosed with prophylaxis, sepsis, stress ulcer and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, small intestinal obstruction. ZOSYN dosage: unknown. During the same period patient was treated with FAMOTIDINE, IMIPENEM. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on July 10, 2006. Male patient, 90 years of age, weighting 134.5 lb, was diagnosed with pneumonia, sepsis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. ZOSYN dosage: unknown. During the same period patient was treated with FLAGYL, VANCOMYCIN. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on July 11, 2006. Female patient, 69 years of age, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, urticaria, wheezing. ZOSYN dosage: 3.375 MG Q6H IV BOLUS. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on July 12, 2006. Male patient, 53 years of age, weighting 174.2 lb, was diagnosed with gastrointestinal infection, pneumonia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, clostridium difficile colitis. ZOSYN dosage: unknown. During the same period patient was treated with VANCOMYCIN, CEFEPIME. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ZOSYN problem on July 14, 2006. Female patient, 80 years of age, weighting 202.4 lb, was diagnosed with pneumonia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: respiration abnormal. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2006. Male patient was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: oliguria, skin exfoliation. ZOSYN dosage: unknown. Patient died.

Health Professional from UNITED STATES reported ZOSYN problem on Aug 01, 2006. Male patient, 50 years of age, weighting 183.0 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Aug 02, 2006. Male patient, 44 years of age, weighting 183.0 lb, was diagnosed with pneumonia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: pallor, rash erythematous. ZOSYN dosage: unknown. During the same period patient was treated with CLOZARIL, DEPAKOTE, LEVOTHYROXINE, CLINDAMYCIN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOSYN problem on Aug 02, 2006. Male patient, weighting 160.0 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: contraindication to medical treatment, multi-organ failure, swelling. ZOSYN dosage: unknown. Patient was hospitalized. Patient died on 08/26/2005.

ZOSYN problem was reported by a Consumer or non-health professional from CANADA on July 28, 2006. Female patient, 28 years of age, was diagnosed with osteomyelitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: anuria, face oedema, haemodialysis, hepatitis toxic, infusion site anaesthesia, infusion site paraesthesia, lymphadenopathy, nephritis interstitial. ZOSYN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Aug 03, 2006. Male patient, 48 years of age, weighting 420.0 lb, was diagnosed with wound infection pseudomonas and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: neutropenia. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Aug 03, 2006. Male patient, weighting 158.7 lb, was diagnosed with bronchiectasis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Aug 22, 2006. Male patient, 32 years of age, weighting 173.0 lb, was diagnosed with enterococcal infection, osteomyelitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, neutropenia, platelet count increased, pruritus, rash macular. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Female patient, 64 years of age, was diagnosed with infected skin ulcer, diabetes mellitus non-insulin-dependent and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. ZOSYN dosage: unknown. During the same period patient was treated with AVANDAMET, FUROSEMIDE, HYZAAR. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ZOSYN problem on Sept 11, 2006. Female patient, 59 years of age, was diagnosed with abscess limb and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, dyspnoea, paraesthesia, pruritus, salivary hypersecretion. ZOSYN dosage: unknown. Patient died on 08/05/2006.

ZOSYN problem was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Female patient, 59 years of age, was diagnosed with abscess limb and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, paraesthesia, pruritus, salivary hypersecretion. ZOSYN dosage: 3.375 MG EVERY 6 HOURS IV (ONE DOSE). Patient died on 08/05/2006.

Pharmacist from UNITED STATES reported ZOSYN problem on Sept 26, 2006. Female patient, 59 years of age, weighting 291.0 lb, was diagnosed with cellulitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial, rash. ZOSYN dosage: unknown. During the same period patient was treated with CLINDAMYCIN. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Oct 11, 2006. Female patient, weighting 151.5 lb, was diagnosed with gastrointestinal necrosis, thrombosis prophylaxis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. ZOSYN dosage: unknown. During the same period patient was treated with ENOXAPARIN. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Nov 08, 2006. Female patient, child 3 years of age, weighting 36.86 lb, was diagnosed with glycogen storage disorder, infusion and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, erythema, pruritus, pyrexia. ZOSYN dosage: 1500 MG Q6HR IV. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Nov 14, 2006. Male patient, 46 years of age, weighting 272.3 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: overdose, pyrexia. ZOSYN dosage: unknown. During the same period patient was treated with ALBUTEROL SULPHATE AND IPRATROPIUM BROMIDE, ENOXAPARIN, LINEZOLID, PROTONIX, LORAZEPAM, ACETAMINOPHEN, DIAZEPAM, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Nov 14, 2006. Male patient, weighting 264.6 lb, was diagnosed with arthritis bacterial and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: neutropenia. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Nov 14, 2006. Male patient, weighting 233.7 lb, was diagnosed with fistula, liver abscess and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: neutropenia. ZOSYN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Nov 20, 2006. Male patient, weighting 128.0 lb, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: pancytopenia. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Nov 21, 2006. Male patient, 54 years of age, was diagnosed with urinary tract infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. ZOSYN dosage: unknown. During the same period patient was treated with FENTANYL, ATIVAN, ASCORBIC ACID, REGLAN, MAALOX FAST BLOCKER. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported ZOSYN problem on Nov 28, 2006. Male patient, 52 years of age, weighting 226.2 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: chest discomfort, flushing, infusion related reaction. ZOSYN dosage: unknown. During the same period patient was treated with ASCORBIC ACID, CIPROFLOXACIN, CODEINE, DICLOFENAC NA, LISINOPRIL, OMEPRAZOLE, SULFAMETHOXAZOLE, VITAMIN E. Patient recovered.

ZOSYN problem was reported by a Health Professional from UNITED STATES on Nov 28, 2006. Female patient, 58 years of age, weighting 116.8 lb, was diagnosed with pneumonia aspiration and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: leukopenia, thrombocytopenia. ZOSYN dosage: unknown. During the same period patient was treated with LISINOPRIL, NOVOLOG, PREDNISONE, AMLODIPINE, TAMOXIFEN CITRATE, PLAVIX, PRAMIPEXOLE DIHYDROCHLORIDE, MIRTAZAPINE. Patient recovered.

Health Professional from UNITED STATES reported ZOSYN problem on Nov 27, 2006. Male patient, 61 years of age, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, pruritus, rash erythematous. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Feb 06, 2006. Male patient, 56 years of age, weighting 449.7 lb, was diagnosed with cellulitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, nephritis interstitial. ZOSYN dosage: unknown. During the same period patient was treated with INSULIN, LEVOTHYROXINE, NORVASC. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Apr 04, 2006. Male patient, 59 years of age, weighting 151.1 lb, was diagnosed with abscess and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: hepatitis, myalgia, neutropenia, pyrexia, thrombocytopenia. ZOSYN dosage: unknown. During the same period patient was treated with SERTRALINE. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Mar 16, 2006. Male patient, 14 years of age, weighting 97.00 lb, was diagnosed with condition aggravated, cystic fibrosis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. ZOSYN dosage: unknown. During the same period patient was treated with TOBRAMYCIN, BENADRYL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZOSYN problem on Dec 12, 2006. Male patient, 58 years of age, weighting 162.3 lb, was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, swelling. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Dec 13, 2006. Female patient, 76 years of age, weighting 169.2 lb, was diagnosed with ileus and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, bradycardia. ZOSYN dosage: unknown. During the same period patient was treated with PROTONIX, INSULIN, ANCEF, SOLUCORT, SOLLUCORT, HYDROCORTISONE. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Dec 20, 2006. Male patient, 74 years of age, was diagnosed with pneumonia and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: sepsis, thrombocytopenia. ZOSYN dosage: unknown. During the same period patient was treated with HEPARIN, LINEZOLID. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2006. Female patient, 94 years of age, weighting 131.1 lb, was diagnosed with staphylococcal infection, urinary tract infection bacterial and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure, haemoglobin decreased, iatrogenic injury, myocardial infarction, operative haemorrhage, platelet count decreased. ZOSYN dosage: 3.37 MG 1X PER 6 HR, INTRAVENOUS. During the same period patient was treated with TYGACIL, ZYVOX, MEROPENEM, CEFTAZIDIME, LOVENOX. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on July 19, 2007. Male patient, weighting 235.0 lb, was diagnosed with coronary artery stenosis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, infusion related reaction, rash pruritic. ZOSYN dosage: unknown. During the same period patient was treated with LEVAQUIN. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on July 23, 2007. Female patient, child 4 years of age, weighting 36.00 lb, was diagnosed with appendicitis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. ZOSYN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ZOSYN problem on July 23, 2007. Female patient, 29 years of age, was diagnosed with pyelonephritis, sepsis and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, rash, swelling. ZOSYN dosage: unknown. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Aug 14, 2007. Female patient, 45 years of age, weighting 154.3 lb, was diagnosed with infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: pancytopenia. ZOSYN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Aug 27, 2007. Female patient, 60 years of age, weighting 127.9 lb, was diagnosed with pneumonia aspiration and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. ZOSYN dosage: unknown. Patient was hospitalized. Patient recovered.

ZOSYN problem was reported by a Pharmacist from UNITED STATES on Aug 28, 2007. Male patient, 74 years of age, was diagnosed with pneumonia necrotising and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. ZOSYN dosage: 4500 MG EVERY 6 HR IV. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZOSYN problem on Sept 27, 2007. Female patient, 69 years of age, weighting 180.0 lb, was diagnosed with diabetic foot infection and was treated with ZOSYN. After drug was administered, patient experienced the following problems/side effects: chills, haematocrit decreased, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. ZOSYN dosage: unknown. Patient recovered.

Ask Our Patient Community about ZOSYN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert